On Feb. 1, the federal government announced a $231.8 million deal to boost availability of the over-the-counter test, called the Ellume COVID-19 Home Test. In a press release, Ellume said the contract will pay for construction of its first manufacturing plant in the U.S. Once completed, the plant will produce up to 19 million tests per month, according to the company.

Could have been us.